An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

OBJECTIVES: To obtain routine clinical practice data on cabazitaxel usage patterns for patients with metastatic castration‐resistant prostate cancer (mCRPC) and to describe physician‐assessed cabazitaxel effectiveness, health‐related quality of life (HRQoL) and safety. PATIENTS AND METHODS: CAPRISTA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BJU Int
Main Authors: Carles, Joan, Pichler, Angelika, Korunkova, Hana, Tomova, Antoaneta, Ghosn, Marwan, El Karak, Fadi, Makdessi, Joseph, Koroleva, Irina, Barnes, Gisoo, Bury, Denise, Özatilgan, Ayse, Hitier, Simon, Katolicka, Jana
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Urological Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379594/
https://ncbi.nlm.nih.gov/pubmed/30098093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados